Literature DB >> 20599199

Risk factors for cerebral ischemic events in patients with atrial fibrillation on warfarin for stroke prevention.

Maurizio Paciaroni1, Giancarlo Agnelli, Walter Ageno, Valeria Caso, Francesco Corea, Alessia Lanari, Andrea Alberti, Paolo Previdi, Marta Fedele, Giorgia Manina, Cristina Vedovati, Michele Venti, Antonia M R Billeci, Maurizio Batta, Luca Galli, Giorgio Silvestrelli.   

Abstract

BACKGROUND AND PURPOSES: Patients with atrial fibrillation (AF) on treatment with oral anticoagulants may still suffer ischemic cerebrovascular events. The aim of this study was to evaluate the risk factors for cerebral ischemic events in warfarin-treated AF patients with an International Normalized Ratios (INR) above 1.8 on admission.
METHODS: In a case-control study, cases were consecutive patients with AF who were on warfarin and who were admitted to four Italian hospitals after an acute cerebrovascular ischemic event (ischemic stroke or transient ischemic attack) with an INR above 1.8. Controls were selected from a single anticoagulation clinic and were patients with AF on adequate warfarin treatment who did not suffer cerebrovascular events.
RESULTS: Cases were identified among 4785 consecutive patients with an ischemic cerebral event. 148 cases (3.1%, 21 with transient ischemic events and 127 with ischemic strokes) had AF and were taking warfarin with an INR above 1.8 on admission. On multivariate analysis, diabetes (OR 3.8; 95% CI 1.09-13.82, p=0.025), hyperlipidemia (OR 4.5; 95% CI 1.11-18.23, p=0.035) and carotid/vertebral atherosclerosis on ultrasound (OR 3.0; 95% CI 1.13-8.41, p=0.028) were independent predictors for ischemic cerebral events. The use of statins was inversely correlated with an ischemic event (OR 0.1; 95% CI 0.06-0.47. p=0.001).
CONCLUSIONS: Carotid/vertebral atherosclerosis, diabetes and hyperlipidemia are associated with an increased risk for ischemic events in patients with AF on adequate warfarin treatment. Statins significantly reduce the risk of ischemic events.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599199     DOI: 10.1016/j.atherosclerosis.2010.06.016

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  11 in total

1.  Laboratory characteristics of ischemic stroke patients with atrial fibrillation on or off therapeutic warfarin.

Authors:  Raghav V Aachi; Lee A Birnbaum; Christopher H Topel; Ali Seifi; Shaheryar Hafeez; Réza Behrouz
Journal:  Clin Cardiol       Date:  2017-12-18       Impact factor: 2.882

Review 2.  Solutions to Reduce Cardiovascular Events in Patients with Atrial Fibrillation.

Authors:  Maurizio Paciaroni; Giancarlo Agnelli
Journal:  J Atr Fibrillation       Date:  2012-10-06

Review 3.  Direct oral anticoagulants in the secondary prevention of stroke and transient ischemic attack in patients with atrial fibrillation.

Authors:  Valentina Arnao; Giancarlo Agnelli; Maurizio Paciaroni
Journal:  Intern Emerg Med       Date:  2015-04-11       Impact factor: 3.397

4.  Increased risk of atrial fibrillation in patients with benign prostatic hyperplasia: A population-based cohort study.

Authors:  Wei-Syun Hu; Cheng-Li Lin
Journal:  Clin Cardiol       Date:  2018-10-02       Impact factor: 2.882

Review 5.  Practical Issues to Prevent Stroke Associated with Non-valvular Atrial Fibrillation.

Authors:  Chi Kyung Kim; Seunguk Jung; Byung-Woo Yoon
Journal:  J Stroke       Date:  2013-09-27       Impact factor: 6.967

6.  Factors associated with ischemic stroke on therapeutic anticoagulation in patients with nonvalvular atrial fibrillation.

Authors:  Young Dae Kim; Kyung Yul Lee; Hyo Suk Nam; Sang Won Han; Jong Yun Lee; Han-Jin Cho; Gyu Sik Kim; Seo Hyun Kim; Myoung-Jin Cha; Seong Hwan Ahn; Seung-Hun Oh; Kee Ook Lee; Yo Han Jung; Hye-Yeon Choi; Sang-Don Han; Hye Sun Lee; Chung Mo Nam; Eun Hye Kim; Ki Jeong Lee; Dongbeom Song; Hui-Nam Park; Ji Hoe Heo
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

7.  Effects of atrial fibrillation on the outcome of the rehabilitation in patients with cerebral infarction.

Authors:  Ja-Young Kim; Su-Jin Lee; Jin-Hong Kim; Cheol-Min Choi; Seo-Ra Yoon; Kwang-Ik Jung
Journal:  Ann Rehabil Med       Date:  2014-12-24

8.  High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin.

Authors:  Oliviero Olivieri; Gianni Turcato; Manuel Cappellari; Filippo Stefanoni; Nicola Osti; Francesca Pizzolo; Simonetta Friso; Antonella Bassi; Annalisa Castagna; Nicola Martinelli
Journal:  Front Cardiovasc Med       Date:  2022-02-04

9.  Differences Between Anticoagulated Patients With Ischemic Stroke Versus Intracerebral Hemorrhage.

Authors:  Fabian Schaub; Alexandros A Polymeris; Sabine Schaedelin; Lisa Hert; Louisa Meya; Sebastian Thilemann; Christopher Traenka; Benjamin Wagner; David Seiffge; Henrik Gensicke; Gian Marco De Marchis; Leo Bonati; Stefan T Engelter; Nils Peters; Philippe Lyrer
Journal:  J Am Heart Assoc       Date:  2021-12-22       Impact factor: 6.106

10.  Atrial Fibrillation Increases the Risk of Peripheral Arterial Disease With Relative Complications and Mortality: A Population-Based Cohort Study.

Authors:  Chia-Jung Chang; Yen-Ting Chen; Chiu-Shong Liu; Wen-Yuan Lin; Cheng-Li Lin; Ming-Chia Lin; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.